NQF:  

The Steering Committee is expected to begin meeting in August 2012 to evaluate the submissions and prepare the draft report. 

• 0403: Medical Visit  (revised)
• 0405: Pneumocystis Jiroveci Pneumonia (PCP) Prophylaxis  (revised)
• 0408: Tuberculosis (TB) Screening  (revised)
• 0409: Sexually Transmitted Diseases - Screening for Chlamydia, Gonorrhea, and Syphilis (revised) 
• 2079: Medical Visit Frequency (revised)
• 2080: Gap in Medical Visits (revised)
• 2081: Newly Enrolled in Medical Care (revised)

• 0404: CD4 Cell Count or Percentage Performed (revised) 
• 0406: Adoloscent and Adult Patients who are Prescribed Potent Antiretroviral Therapy (revised)
• 0407: HIV RNA Control After Six Months of Potent Antiretroviral Therapy 
• 0412: Hepatitis B Vaccination  
• 2082: Viral Load Suppression (revised)
• 2083: Prescription of HIV Antiretroviral Therapy (revised)

• 0393: Testing for Chronic Hepatitis C - Confirmation of Hepatitis C Viremia (revised)
• 0394: Counseling Regarding Use of Contraception Prior to Antiviral Treatment (revised)
• 0395: Hepatitis C Ribonucleic Acid (RNA) Testing Before Initiating Treatment (paired with 0396) (revised)
• 0396: HCV Genotype Testing Prior to Treatment (paired with 0395) (revised)
• 0397: Antiviral Treatment Prescribed 
• 0398: HCV RNA Testing at No Greater Than Week 12 of Treatment (revised)
• 0584: Viral Load Test  (revised)

• 0058: Avoidance of Antibiotic Treatment in Adults with Acute Bronchitis (revised) 
• 0069: Appropriate Treatment for Children with Upper Respiratory Infection (URI) 
• 0399: Hepatitis A Vaccination (revised) 
• 0400: Hepatitis B Vaccination  
• 0401: Counseling Regarding Risk of Alcohol Consumption 
• 0500: Severe Sepsis and Septic Shock: Management Bundle (revised) 
• 0298: Central Line Bundle Compliance